1565 studies found for:    Open Studies | "Lymphatic Diseases"
Show Display Options
Rank Status Study
21 Not yet recruiting Phase I/II Study of Nilotinib/Ruxolitinb Therapy for TKI Resistant Ph-Leukemia
Conditions: Chronic Phase Chronic Myeloid Leukemia;   Accelerated Phase Chronic Myeloid Leukemia;   Blastic Phase Chronic Myeloid Leukemia;   Philadelphia Positive Acute Lymphoblastic Leukemia;   Resistant to Tyrosine Kinase Inhibitor Therapy
Interventions: Drug: Nilotinib;   Drug: Ruxolitinib
22 Unknown  Functional Pharmacogenomics of Childhood Acute Lymphoblastic Leukemia in Taiwan
Condition: Leukemia, Lymphocytic, Acute
Intervention:
23 Recruiting Chemotherapy Based on PET Scan in Treating Patients With Stage I or Stage II Hodgkin Lymphoma
Condition: Lymphoma
Interventions: Biological: bleomycin sulfate;   Drug: ABVD regimen;   Drug: BEACOPP regimen;   Drug: cyclophosphamide;   Drug: dacarbazine;   Drug: doxorubicin hydrochloride;   Drug: etoposide;   Drug: prednisone;   Drug: procarbazine hydrochloride;   Drug: vinblastine;   Drug: vincristine sulfate;   Other: laboratory biomarker analysis;   Procedure: computed tomography;   Radiation: fludeoxyglucose F 18;   Radiation: selective external radiation therapy
24 Recruiting Administration of Jakafi (Ruxolitinib) for Symptom Control of Patients With Chronic Lymphocytic Leukemia (CLL): Phase II
Condition: Leukemia
Interventions: Drug: Ruxolitinib;   Behavioral: Questionnaire
25 Recruiting A Study Of Inotuzumab Ozogamicin Versus Investigator's Choice Of Chemotherapy In Patients With Relapsed Or Refractory Acute Lymphoblastic Leukemia
Condition: Acute Lymphoblastic Leukemia
Interventions: Drug: inotuzumab ozogamicin;   Drug: FLAG (fludarabine, cytarabine and G-CSF);   Drug: HIDAC (high dose cytarabine);   Drug: cytarabine and mitoxantrone
26 Recruiting An Observational Study Examining the Effect of Added MabThera Therapy in Patients With Untreated Chronic Lymphocytic Leukemia
Condition: Chronic Lymphocytic Leukemia
Intervention:
27 Recruiting A Phase I-II Open Label Non-Randomized Study Using TL32711 for Patients With Acute Myelogenous Leukemia, Myelodysplastic Syndrome and Acute Lymphoblastic Leukemia
Condition: Acute Myelogenous Leukemia
Intervention: Drug: TL32711
28 Recruiting Infusion of Allogeneic CD19-Specific T Cells From Peripheral Blood
Conditions: Leukemia;   Lymphoma
Interventions: Procedure: HSCT;   Genetic: DLI
29 Unknown  Description and Prognostic Evaluation of Four Biological Parameters of Blast Cells in Adult Acute Lymphoblastic Leukemia
Condition: Adult Acute Lymphoblastic Leukemia
Interventions: Procedure: DNA Index;   Procedure: S-Phase%;   Procedure: CD45 expression;   Procedure: P16 metabolic way
30 Recruiting Ex-vivo Perfusion and Ventilation of Lungs Recovered From Non-Heart-Beating Donors to Assess Transplant Suitability
Conditions: Emphysema;   Chronic Obstructive Pulmonary Disease (COPD);   Cystic Fibrosis;   Pulmonary Fibrosis;   Bronchiectasis;   Sarcoidosis;   Pulmonary Hypertension;   Alpha-1 Antitrypsin Deficiency
Interventions: Procedure: Transplantation of lungs obtained from Non-Heart-Beating Donors (NHBDs) after ex-vivo perfusion w/ STEEN Solution™;   Device: STEEN Solution™
31 Not yet recruiting Burkitt Leukemia - Dose-Adjusted Etoposide, Prednisone, Vincristine, Cyclophosphamide, and Ofatumumab (EPOCH - O)
Condition: Leukemia
Interventions: Drug: Ofatumumab;   Drug: Etoposide;   Drug: Doxorubicin;   Drug: Vincristine;   Drug: Cyclophosphamide;   Drug: Prednisone;   Drug: Rituximab;   Drug: Pegfilgrastim;   Drug: G-CSF;   Behavioral: Phone Calls
32 Recruiting Microwave Ablation and Partial Splenic Embolization in the Management of Hypersplenism
Condition: Hypersplenism
Interventions: Device: Microwave Thermal Coagulation;   Device: Partial Splenic Embolization
33 Recruiting Administered as Intravenous (IV) Infusion in Children and Young Adults With Acute Leukemia or Lymphoma
Conditions: Acute Lymphoblastic Leukemia;   Lymphoblastic Lymphoma
Intervention: Drug: pegcrisantaspase
34 Recruiting CAR T Cells Targeting CD30 Positive Lymphomas (4SCAR30273)
Condition: Lymphomas
Intervention: Genetic: Anti-CD30 CAR T cells
35 Unknown  Early Evaluation of the Response of Large B Cell Non Hodgkin’s Lymphoma to Chemotherapy by PET/CT
Condition: Lymphoma, Large-Cell
Intervention: Procedure: PET/CT 20 days after the first cycle of chemotherapy
36 Recruiting A Pilot Study of Decitabine and Vorinostat With Chemotherapy for Relapsed ALL
Conditions: Acute Lymphoblastic Leukemia;   Precursor B-Cell Lymphoblastic Leukemia;   Precursor T-Cell Lymphoblastic Leukemia
Interventions: Drug: Decitabine;   Drug: Vorinostat;   Drug: Vincristine;   Drug: Dexamethasone;   Drug: Mitoxantrone;   Drug: Pegaspargase;   Drug: Methotrexate
37 Recruiting Safety Study of SGN-CD70A in Cancer Patients
Conditions: Renal Cell Carcinoma;   Mantle-Cell Lymphoma;   Diffuse, Large B-Cell, Lymphoma;   Follicular Lymphoma, Grade 3
Intervention: Drug: SGN-CD70A
38 Not yet recruiting Transplant-Related Mortality in Patients Undergoing a Peripheral Blood Stem Cell Transplantation or an Umbilical Cord Blood Transplantation
Conditions: Acute Myeloid Leukemia;   Acute Lymphoblastic Leukemia;   Myelodysplastic Syndrome
Intervention:
39 Unknown  Alemtuzumab and Combination Chemotherapy in Treating Patients With Newly Diagnosed Stage II, Stage III, or Stage IV T-Cell Non-Hodgkin's Lymphoma
Condition: Lymphoma
Interventions: Biological: alemtuzumab;   Drug: cyclophosphamide;   Drug: doxorubicin hydrochloride;   Drug: prednisone;   Drug: vincristine sulfate;   Other: flow cytometry;   Other: pharmacological study
40 Recruiting Ofatumumab for High-Risk Chronic Lymphocytic Leukemia (CLL)
Condition: Chronic Lymphocytic Leukemia
Intervention: Drug: Ofatumumab

First Page    Show previous page of results Previous Page (1-20) Studies Shown (21-40) Next Page (41-60) Show next page of results    Last Page
Indicates status has not been verified in more than two years